Forte Biosciences, Inc. — Director's Dealing 2018

Jun 25, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tocagen Inc (TOCA)
CIK: 0001419041
Period of Report: 2018-06-21

Reporting Person: Parkinson David Ross (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-21	Stock option (right to buy)	$8.98	A	20000	Acquired	2028-06-20	Common Stock (20000)	Direct

Footnotes

F1: The stock option vests and becomes exercisable in 12 monthly installments following the date of grant.